Close Menu

Danaher

The impending acquisition will give Danaher ownership of MDS' Molecular Devices business, which in turn sells the Axon GenePix line of scanners that are widely used by researchers.

The company shipped its tenth Polonator last month and has several pending orders, according to a Dover official.

The shareholders will meet in October to vote on the deal to sell the firm's MDS Analytical Technologies division to Danaher.

Danaher will spend $1.1 billion to acquire the mass spec joint venture of MDS and Life Technologies, as well as the Molecular Devices business owned by MDS. It expects those businesses to add $650 million in annual revenues to its life sciences segment.

Over the next year or so, Polonator developers plan additional improvements, including reagent kits, increased read lengths, and a simpler library preparation protocol. By 2010, they expect the output per run to increase tenfold, to 100 gigabases.

PerkinElmer CEO Robert Friel was named chairman, as the firm also announced a new CFO. Integrated Genomics appointed members to its SAB, and John Rossi won a prize from PNAS.

Paired Ends: Mar 31, 2009

Premium

Greg Porreca, Adam Cohen, David Cumming, Michael Deem, Jim Lupski, Amy McGuire, Antoine van Oijen, Ian Ratcliffe

Enzymatics received ISO standards certification for manufacturing its proteins that are used for research and diagnostics purposes with a focus on nucleic acid detection technologies.

Pages

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.